Yuanhui Lai

No 58, Zhongshan 2 Road
Guangzhou, 510080, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Development and validation of a prognostic model for stage IV breast cancer based on primary tumor resection with machine learning methods: retrospective cohort study.

Development and validation of a prognostic model for stage IV breast cancer based on primary tumor resection with machine learning methods: retrospective cohort study.

Journal: Frontiers in endocrinology
Published: May 03, 2026

Correction: CircCD44 plays oncogenic roles in triple-negative breast cancer by modulating the miR-502-5p/KRAS and IGF2BP2/Myc axes.

Correction: CircCD44 plays oncogenic roles in triple-negative breast cancer by modulating the miR-502-5p/KRAS and IGF2BP2/Myc axes.

Journal: Molecular cancer
Published: February 14, 2025

Discovery of an Efficacious RET PROTAC Degrader with Enhanced Antiproliferative Activity against Resistant Cancer Cells Harboring RET Solvent-Front Mutations.

Discovery of an Efficacious RET PROTAC Degrader with Enhanced Antiproliferative Activity against Resistant Cancer Cells Harboring RET Solvent-Front Mutations.

Journal: Journal of medicinal chemistry
Published: December 28, 2024

Discovery of a first-in-class PROTAC degrader of histone lysine demethylase KDM4.

Discovery of a first-in-class PROTAC degrader of histone lysine demethylase KDM4.

Journal: European journal of medicinal chemistry
Published: December 20, 2024

Intervention time decides the status of autophagy, NLRP3 activity and apoptosis in macrophages induced by ox-LDL.

Intervention time decides the status of autophagy, NLRP3 activity and apoptosis in macrophages induced by ox-LDL.

Journal: Lipids in health and disease
Published: August 18, 2022

CircCD44 plays oncogenic roles in triple-negative breast cancer by modulating the miR-502-5p/KRAS and IGF2BP2/Myc axes.

CircCD44 plays oncogenic roles in triple-negative breast cancer by modulating the miR-502-5p/KRAS and IGF2BP2/Myc axes.

Journal: Molecular cancer
Published: May 12, 2021

Breast lesions excised via vacuum-assisted system: could we get any clues for B3 lesions before excision biopsy?

Breast lesions excised via vacuum-assisted system: could we get any clues for B3 lesions before excision biopsy?

Journal: BMC cancer
Published: March 12, 2021

Long Non-coding RNA RP11-480I12.5 Promotes the Proliferation, Migration, and Invasion of Breast Cancer Cells Through the miR-490-3p-AURKA-Wnt/β-Catenin Axis.

Long Non-coding RNA RP11-480I12.5 Promotes the Proliferation, Migration, and Invasion of Breast Cancer Cells Through the miR-490-3p-AURKA-Wnt/β-Catenin Axis.

Journal: Frontiers in oncology
Published: February 19, 2020

Mitochondrial fission regulator 2 (MTFR2) promotes growth, migration, invasion and tumour progression in breast cancer cells.

Mitochondrial fission regulator 2 (MTFR2) promotes growth, migration, invasion and tumour progression in breast cancer cells.

Journal: Aging
Published: August 22, 2019

Over expression of GPR30, indicating poor prognosis and promoting proliferation, upregulates Beclin-1 expression via p38MAPK signaling in esophageal squamous cell carcinoma progression.

Over expression of GPR30, indicating poor prognosis and promoting proliferation, upregulates Beclin-1 expression via p38MAPK signaling in esophageal squamous cell carcinoma progression.

Journal: International journal of clinical and experimental pathology
Published: February 06, 2018

miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.

miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.

Journal: BMC cancer
Published: March 31, 2017

Inhibition of mTOR sensitizes breast cancer stem cells to radiation-induced repression of self-renewal through the regulation of MnSOD and Akt.

Inhibition of mTOR sensitizes breast cancer stem cells to radiation-induced repression of self-renewal through the regulation of MnSOD and Akt.

Journal: International journal of molecular medicine
Published: July 24, 2015
Showing 1-12 of 15

Last Updated: 09/26/2026